Corrections



FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.


FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

Am Fam Physician. 2006 May 15;73(10):1704.

The article “Preventive Counseling, Screening, and Therapy for the Patient with Newly Diagnosed HIV Infection” (January 15, 2006, page 271) contained an error in the last recommendation of the “SORT: Key Recommendations for Practice” table regarding the CD4+ cell counts at which antibiotic prophylaxis for toxoplasmosis and Mycobacterium avium-intracellulare complex should be initiated (the cutoffs were inadvertently transposed). The recommendation should have read as follows: “Antibiotic prophylaxis should be used to prevent toxoplasmosis and Mycobacterium avium-intracellulare complex infection at CD4+ cell counts below 100 and below 50 cells per mm3, respectively.” The online version of this article has been corrected and the corrected SORT table appears below.

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendation Evidence rating References

Patients with HIV should be monitored for CD4+ lymphocyte and HIV RNA levels every three to six months.

C

7, 8, 26, 28

Patients who are hepatitis A or B nonimmune at baseline should be vaccinated.

B

7, 8, 25

Tuberculosis prophylaxis should be given to patients with any of the following: history or symptoms of tuberculosis, a PPD of at least 5 mm, or a possible false-negative PPD.

C

7, 8, 25

Pneumocystis jiroveci prophylaxis with trimethoprim/sulfamethoxazole (Bactrim, Septra) should be initiated at CD4+ counts of less than 200 cells per mm3.

A

7, 8, 25

Women with HIV should have Pap smears every six months for the first year and, if normal, annual Pap smears thereafter.

C

7, 8, 25

High-risk patients with ongoing exposure should be checked annually for gonorrhea, chlamydia, syphilis, and hepatitis C.

C

7, 8, 25

Antibiotic prophylaxis should be used to prevent toxoplasmosis and Mycobacterium avium-intracellulare complex infection at CD4+ cell counts below 100 and below 50 cells per mm3, respectively.

B

7, 8, 25


HIV = human immunodeficiency virus; PPD = purified protein derivative; Pap = Papanicolaou.

A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, see http://www.aafp.org/afpsort.xml.

SORT: KEY RECOMMENDATIONS FOR PRACTICE

View Table

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendation Evidence rating References

Patients with HIV should be monitored for CD4+ lymphocyte and HIV RNA levels every three to six months.

C

7, 8, 26, 28

Patients who are hepatitis A or B nonimmune at baseline should be vaccinated.

B

7, 8, 25

Tuberculosis prophylaxis should be given to patients with any of the following: history or symptoms of tuberculosis, a PPD of at least 5 mm, or a possible false-negative PPD.

C

7, 8, 25

Pneumocystis jiroveci prophylaxis with trimethoprim/sulfamethoxazole (Bactrim, Septra) should be initiated at CD4+ counts of less than 200 cells per mm3.

A

7, 8, 25

Women with HIV should have Pap smears every six months for the first year and, if normal, annual Pap smears thereafter.

C

7, 8, 25

High-risk patients with ongoing exposure should be checked annually for gonorrhea, chlamydia, syphilis, and hepatitis C.

C

7, 8, 25

Antibiotic prophylaxis should be used to prevent toxoplasmosis and Mycobacterium avium-intracellulare complex infection at CD4+ cell counts below 100 and below 50 cells per mm3, respectively.

B

7, 8, 25


HIV = human immunodeficiency virus; PPD = purified protein derivative; Pap = Papanicolaou.

A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, see http://www.aafp.org/afpsort.xml.


Copyright © 2006 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

Navigate this Article